Aspirin May Lower Lung Cancer Risk in Women But Still Has RisksPosted on June 8, 2017
Aspirin has a new benefit according to a recent NBC news story. According to the story a recent study of more than 1,200 Asian women, those who consumed an aspirin at least a couple of times a week had a reduced risk of developing lung cancer — whether they had ever smoked or not. The discovery, which associates consistently taking aspirin with a risk reduction of 50 percent or more, did not prove that aspirin directly provides protection against lung cancer. There may be other reasons for the connection. The study supports a number of previous studies associating regular aspirin use to reduce risks of certain cancers, including colon, prostate and esophageal cancers. Still, experts believe that it is too early to recommend widespread aspirin use for reducing cancer risk. Even low-dose aspirin carries associated risks, like stomach irritation and ulcers. Avoiding tobacco smoke is still the best way to protect yourself experts warn. Dr. Kim reminds patients that aspirin use prior to cosmetic procedures including noninvasive procedures as well as surgery is not advised. Patients who are scheduled for injectables including Botox and injectable fillers should not take aspirin at least two weeks prior to their injection. Aspirin increases the risk of bleeding and bruising. Patients who are scheduled for surgery, even shorter surgeries like breast augmentation, and liposuction, are also advised to discontinue aspirin and other medications at least two weeks prior to surgery. Patients who are on a daily aspirin regimen prior to scheduling surgery, may be required to stop at least three or more weeks prior to surgery. Dr. Kim is committed to providing the best possible results in the safest manner possible.